Antiemetics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Antiemetics Market to 2027 - Global Analysis and Forecasts By Drug Class(5-HT3 Receptor Antagonists, NK1 Receptor Antagonist, Dopamine Antagonists, Antihistamines, Cannabinoids, Benzodiazepines, Corticosteroids and Anticholinergic); Application(Chemotherapy-Induced Nausea and Vomiting, Gastroenteritis, Nausea and Vomiting of Pregnancy (NVP) and Post-Operative Nausea and Vomiting)

Report Code: TIPRE00003744 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Antiemetics are drugs used for treating the side effects of other medications including opoid analgesics, chemotherapy and general anesthetics. These therapeutic agents are also effective against nausea and vomiting caused due to several medical conditions such as sickness, dizziness, pregnancy, emotional stress and food poisoning.

MARKET DYNAMICS
The Antiemetics market is anticipated to grow in the forecast period owing to driving factors such as expanding geriatric population, increasing prevalence of cancer mostly treated through chemotherapy and rising number of gastroenteritis patients. Nevertheless, the increasing cost R&D may hamper the growth of the market during forecast period.

MARKET SCOPE
The "Global Antiemetics Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Antiemetics market with detailed market segmentation by Drug Class, Application and Geography. The Antiemetics is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Antiemetics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The Antiemetics is segmented by Drug Class and Application. On the basis of Drug Class the market is segmented into 5-HT3 Receptor Antagonists, NK1 Receptor Antagonist, Dopamine Antagonists, Antihistamines, Cannabinoids, Benzodiazepines, Corticosteroids and Anticholinergic. On the basis of Application the market is segmented into Chemotherapy-Induced Nausea and Vomiting, Gastroenteritis, Nausea and Vomiting of Pregnancy (NVP) and Post-Operative Nausea and Vomiting.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Antiemetics based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Antiemetics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Antiemetics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Antiemetics market in these regions.

MARKET PLAYERS
The reports cover key developments in the Antiemetics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Antiemetics Market are anticipated to lucrative growth opportunities in the future with the rising demand for Antiemetics in the global market. Below mentioned is the list of few companies engaged in the Antiemetics market.

The report also includes the profiles of key Antiemetics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Abbott
  • Astellas Pharma
  • Aphios Corp.
  • Aurobindo Pharma
  • Daiichi Sankyo Company Ltd.
  • Eisai Co., Inc.
  • Glaxosmithkline Plc
  • Helsinn Healthcare Sa
  • Heron Therapeutics, Inc.
  • Ipca Laboratories, Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antiemetics Market - By Drug Class
1.3.2 Antiemetics Market - By Application
1.3.3 Antiemetics Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ANTIEMETICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIEMETICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIEMETICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIEMETICS - GLOBAL MARKET OVERVIEW
6.2. ANTIEMETICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIEMETICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. 5-HT3 RECEPTOR ANTAGONISTS
7.3.1. Overview
7.3.2. 5-HT3 Receptor Antagonists Market Forecast and Analysis
7.4. NK1 RECEPTOR ANTAGONIST
7.4.1. Overview
7.4.2. NK1 Receptor Antagonist Market Forecast and Analysis
7.5. DOPAMINE ANTAGONISTS
7.5.1. Overview
7.5.2. Dopamine Antagonists Market Forecast and Analysis
7.6. ANTIHISTAMINES
7.6.1. Overview
7.6.2. Antihistamines Market Forecast and Analysis
7.7. CANNABINOIDS
7.7.1. Overview
7.7.2. Cannabinoids Market Forecast and Analysis
7.8. BENZODIAZEPINES
7.8.1. Overview
7.8.2. Benzodiazepines Market Forecast and Analysis
7.9. CORTICOSTEROIDS
7.9.1. Overview
7.9.2. Corticosteroids Market Forecast and Analysis
7.10. ANTICHOLINERGIC
7.10.1. Overview
7.10.2. Anticholinergic Market Forecast and Analysis
8. ANTIEMETICS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
8.3.1. Overview
8.3.2. Chemotherapy-Induced Nausea and Vomiting Market Forecast and Analysis
8.4. GASTROENTERITIS
8.4.1. Overview
8.4.2. Gastroenteritis Market Forecast and Analysis
8.5. NAUSEA AND VOMITING OF PREGNANCY
8.5.1. Overview
8.5.2. Nausea and Vomiting of Pregnancy Market Forecast and Analysis
8.6. POST-OPERATIVE NAUSEA AND VOMITING
8.6.1. Overview
8.6.2. Post-Operative Nausea and Vomiting Market Forecast and Analysis
9. ANTIEMETICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antiemetics Market Overview
9.1.2 North America Antiemetics Market Forecasts and Analysis
9.1.3 North America Antiemetics Market Forecasts and Analysis - By Drug Class
9.1.4 North America Antiemetics Market Forecasts and Analysis - By Application
9.1.5 North America Antiemetics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antiemetics Market
9.1.5.1.1 United States Antiemetics Market by Drug Class
9.1.5.1.2 United States Antiemetics Market by Application
9.1.5.2 Canada Antiemetics Market
9.1.5.2.1 Canada Antiemetics Market by Drug Class
9.1.5.2.2 Canada Antiemetics Market by Application
9.1.5.3 Mexico Antiemetics Market
9.1.5.3.1 Mexico Antiemetics Market by Drug Class
9.1.5.3.2 Mexico Antiemetics Market by Application
9.1.5.4 US Antiemetics Market
9.1.5.4.1 US Antiemetics Market by Drug Class
9.1.5.4.2 US Antiemetics Market by Application
9.2. EUROPE
9.2.1 Europe Antiemetics Market Overview
9.2.2 Europe Antiemetics Market Forecasts and Analysis
9.2.3 Europe Antiemetics Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Antiemetics Market Forecasts and Analysis - By Application
9.2.5 Europe Antiemetics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antiemetics Market
9.2.5.1.1 Germany Antiemetics Market by Drug Class
9.2.5.1.2 Germany Antiemetics Market by Application
9.2.5.2 France Antiemetics Market
9.2.5.2.1 France Antiemetics Market by Drug Class
9.2.5.2.2 France Antiemetics Market by Application
9.2.5.3 Italy Antiemetics Market
9.2.5.3.1 Italy Antiemetics Market by Drug Class
9.2.5.3.2 Italy Antiemetics Market by Application
9.2.5.4 Spain Antiemetics Market
9.2.5.4.1 Spain Antiemetics Market by Drug Class
9.2.5.4.2 Spain Antiemetics Market by Application
9.2.5.5 United Kingdom Antiemetics Market
9.2.5.5.1 United Kingdom Antiemetics Market by Drug Class
9.2.5.5.2 United Kingdom Antiemetics Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antiemetics Market Overview
9.3.2 Asia-Pacific Antiemetics Market Forecasts and Analysis
9.3.3 Asia-Pacific Antiemetics Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Antiemetics Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Antiemetics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antiemetics Market
9.3.5.1.1 Australia Antiemetics Market by Drug Class
9.3.5.1.2 Australia Antiemetics Market by Application
9.3.5.2 China Antiemetics Market
9.3.5.2.1 China Antiemetics Market by Drug Class
9.3.5.2.2 China Antiemetics Market by Application
9.3.5.3 India Antiemetics Market
9.3.5.3.1 India Antiemetics Market by Drug Class
9.3.5.3.2 India Antiemetics Market by Application
9.3.5.4 Japan Antiemetics Market
9.3.5.4.1 Japan Antiemetics Market by Drug Class
9.3.5.4.2 Japan Antiemetics Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antiemetics Market Overview
9.4.2 Middle East and Africa Antiemetics Market Forecasts and Analysis
9.4.3 Middle East and Africa Antiemetics Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Antiemetics Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Antiemetics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antiemetics Market
9.4.5.1.1 South Africa Antiemetics Market by Drug Class
9.4.5.1.2 South Africa Antiemetics Market by Application
9.4.5.2 Saudi Arabia Antiemetics Market
9.4.5.2.1 Saudi Arabia Antiemetics Market by Drug Class
9.4.5.2.2 Saudi Arabia Antiemetics Market by Application
9.4.5.3 U.A.E Antiemetics Market
9.4.5.3.1 U.A.E Antiemetics Market by Drug Class
9.4.5.3.2 U.A.E Antiemetics Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antiemetics Market Overview
9.5.2 South and Central America Antiemetics Market Forecasts and Analysis
9.5.3 South and Central America Antiemetics Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Antiemetics Market Forecasts and Analysis - By Application
9.5.5 South and Central America Antiemetics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antiemetics Market
9.5.5.1.1 Brazil Antiemetics Market by Drug Class
9.5.5.1.2 Brazil Antiemetics Market by Application
9.5.5.2 Argentina Antiemetics Market
9.5.5.2.1 Argentina Antiemetics Market by Drug Class
9.5.5.2.2 Argentina Antiemetics Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANTIEMETICS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTELLAS PHARMA
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. APHIOS CORP
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. AUROBINDO PHARMA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. DAIICHI SANKYO COMPANY LTD
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. EISAI CO., INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GLAXOSMITHKLINE PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. HELSINN HEALTHCARE SA
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. HERON THERAPEUTICS, INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. IPCA LABORATORIES, LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. Astellas Pharma
3. Aphios Corp.
4. Aurobindo Pharma
5. Daiichi Sankyo Company Ltd.
6. Eisai Co., Inc.
7. Glaxosmithkline Plc
8. Helsinn Healthcare Sa
9. Heron Therapeutics, Inc.
10. Ipca Laboratories, Ltd.